Literature DB >> 29440366

Salmonella enterica Serovar Typhimurium Increases Functional PD-L1 Synergistically with Gamma Interferon in Intestinal Epithelial Cells via Salmonella Pathogenicity Island 2.

J M Sahler1, C R Eade2, C Altier2, J C March3.   

Abstract

Nontyphoidal serovars of Salmonella enterica are pathogenic bacteria that are common causes of food poisoning. Whereas Salmonella mechanisms of host cell invasion, inflammation, and pathogenesis are mostly well established, a new possible mechanism of immune evasion is being uncovered. Programmed death ligand 1 (PD-L1) is an immunosuppressive membrane protein that binds to activated T cells via their PD-1 receptor and thereby halts their activation. PD-L1 expression plays an essential role in the immunological tolerance of self-antigens but is also exploited for immune evasion by pathogen-infected cells and cancer cells. Here, we show for the first time that Salmonella infection of intestinal epithelial cells causes the induction of PD-L1. The increased expression of PD-L1 through Salmonella infection was seen in both human and rat intestinal epithelial cell lines. We determined that cellular invasion by the bacteria is necessary for PD-L1 induction, potentially indicating that Salmonella strains are delivering mediators from inside the host cell that trigger the increased PD-L1 expression. Using knockout mutants, we determined that this effect largely originates from the Salmonella pathogenicity island 2. We also show for the first time in any cell type that Salmonella combined with gamma interferon (IFN-γ) causes a synergistic induction of PD-L1. Finally, we show that Salmonella plus IFN-γ induction of PD-L1 decreased the cytokine production of activated T cells. Understanding Salmonella immune evasion strategies could generate new therapeutic targets and help to manipulate PD-L1 expression in other diseases.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  PD-L1; Salmonella

Mesh:

Substances:

Year:  2018        PMID: 29440366      PMCID: PMC5913837          DOI: 10.1128/IAI.00674-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  Anatomical basis of tolerance and immunity to intestinal antigens.

Authors:  Allan McI Mowat
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 2.  Gatekeepers of intestinal inflammation.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Inflamm Res       Date:  2010-01       Impact factor: 4.575

3.  Interrupting Vibrio cholerae infection of human epithelial cells with engineered commensal bacterial signaling.

Authors:  Faping Duan; John C March
Journal:  Biotechnol Bioeng       Date:  2008-09-01       Impact factor: 4.530

Review 4.  Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors.

Authors:  Rita Figueira; David W Holden
Journal:  Microbiology       Date:  2012-03-15       Impact factor: 2.777

Review 5.  Salmonella effector proteins and host-cell responses.

Authors:  C V Srikanth; Regino Mercado-Lubo; Kelly Hallstrom; Beth A McCormick
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

6.  Salmonella induces PD-L1 expression in B cells.

Authors:  Marcela Lopez-Medina; Araceli Perez-Lopez; Celia Alpuche-Aranda; Vianney Ortiz-Navarrete
Journal:  Immunol Lett       Date:  2015-08-17       Impact factor: 3.685

7.  A New Bliss Independence Model to Analyze Drug Combination Data.

Authors:  Wei Zhao; Kris Sachsenmeier; Lanju Zhang; Erin Sult; Robert E Hollingsworth; Harry Yang
Journal:  J Biomol Screen       Date:  2014-02-03

8.  pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium.

Authors:  C R Beuzón; G Banks; J Deiwick; M Hensel; D W Holden
Journal:  Mol Microbiol       Date:  1999-08       Impact factor: 3.501

9.  Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection.

Authors:  Soumita Das; Giovanni Suarez; Ellen J Beswick; Johanna C Sierra; David Y Graham; Victor E Reyes
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

10.  TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.

Authors:  Ellen J Beswick; Jameel R Johnson; Jamal I Saada; Martin Humen; Jenifer House; Sara Dann; Suimin Qiu; Allan R Brasier; Don W Powell; Victor E Reyes; Irina V Pinchuk
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

View more
  4 in total

1.  Escherichia coli K12 Upregulates Programmed Cell Death Ligand 1 (PD-L1) Expression in Gamma Interferon-Sensitized Intestinal Epithelial Cells via the NF-κB Pathway.

Authors:  Seul A Lee; Yiming Wang; Fang Liu; Stephen M Riordan; Lu Liu; Li Zhang
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

Review 2.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 3.  Perspectives on Oncolytic Salmonella in Cancer Immunotherapy-A Promising Strategy.

Authors:  Ding Wang; Xiaodong Wei; Dhan V Kalvakolanu; Baofeng Guo; Ling Zhang
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

4.  Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target.

Authors:  Candelaria Ponce de León; Pedro Lorite; Miguel Ángel López-Casado; Francisco Barro; Teresa Palomeque; María Isabel Torres
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.